July 18, 2018
Category archive


Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests

in AI/Artificial Intelligence/blood testing/Delhi/Europe/Fundings & Exits/Health/India/machine learning/machine vision/Politics/Sight Diagnostics/TC by

Sight Diagnostics, an Israeli medical devices startup that’s using computer vision and machine learning technology to speed up blood testing, is launching a point-of-care blood diagnostics system today.

It claims the compact, desktop machine — called OLO — which analyzes single-use cartridges manually loaded with drops of the patient’s blood, can deliver “lab-grade” complete blood count (CBC) tests from only a finger prick of blood.

The idea being for clinicians to use the device to perform the most prevalent medical blood diagnostics test directly in their office, rather than a patient having venous blood drawn and sent away to a lab for analysis — a process that can take a few days.

They’re also intending to offer a high tech alternative to carrying out manual microscopy on a blood smear — another technique that can be used to conduct an point-of-care CBC test, but which requires specialist personnel taking the time, care and attention to get it right.

The team hasn’t previously disclosed total funding but are now confirming they’ve raised $25 million in equity financing (Series A and B) from VC firms, including Eric Schmidt’s Innovation Endeavors — which they say they’re expecting to take them through their US clinical trials. They are also in the process of raising a Series C. 

Sight Diagnostics is touting OLO as the high tech alternative that healthcare providers have been waiting for — with AI-powered analysis performing a blood count right then and there, after a healthcare worker has pipetted a few drops of the patient’s blood into place.

Sight Diagnostics points out that CBC tests are used to diagnose a broad range of common medical conditions, as well as for the vast majority of baseline tests ordered during routine ‘well visits’, arguing that speeding up this type of routine blood test could support faster diagnostics of medical problems. Or, indeed, speedier reassurance that a person is okay. 

The OLO system uses a patented process for ‘digitizing’ patient blood into a set of specifically colored microscope images. It then applies proprietary machine vision algorithms to the images to identify and count different blood-cell types — with the company claiming its technology simplifies blood testing so that even non-professionals can perform the tests.

According to the company, new sample-preparation methods allow them to present a small amount of blood to OLO’s microscope in a way that is tolerant to inaccuracies in the preparation process — placing what they describe as “minimal burden” on the user — as well as being robust in the face of inaccuracies in any manufacturing processes, saying this means the cost of their testing kits can remain low.

“This novel way of digitizing blood is equally important to our approach as the artificial intelligence driving the analysis,” they add.

Of course any novel blood testing technology claiming a disruptive advantage must be able to prove it is as accurate and robust as traditional lab testing methods.

Very clearly, lives are at stake.

And, well, on the disruptive startup side, the shadow cast by Theranos’ implosion is a very long one.

But — to be clear — Theranos had claimed it could deliver a full battery of laboratory tests from a few drops of blood — not just a CBC count, which is at least the initial aim for OLO. And for CBC tests having only a small blood sample to work is actually not so unusual.

“CBC tests operate even today with low sample volumes,” it says. “For example, several central-lab instruments have been cleared for capillary samples (200-300uL of blood, of which less than 10uL is actually counted), and the older manual method for CBC analysis — the traditional blood smears on microscope slides — uses less than 10uL of blood in total. This is to say that in our domain the use of low sample-volumes stands on solid scientific ground.”

Sight Diagnostics has been working on the OLO system for more than eight years at this stage.

The co-founder duo — Yossi Pollak and Daniel Levner — combine machine vision and AI expertise on the one hand (Pollak worked on algorithms for automotive machine-vision giant Mobileye), with a medical background, via Levner’s postdoctoral fellowship at Harvard Medical School (and later a CTO role at a biotech company, called Emulate).

Their key claim is that OLO produces “lab-quality” CBCs.

More specifically, they say a recent clinical trial compared its CBC analysis against Sysmex XN (“a top-of-the-line lab-grade analyzer”) to determine equivalence.

Here’s what Levner — who’s also chairman of its scientific advisory board — told us on that:

The study included the 19 CBC parameters that make up the 5-differential (‘5-diff’) CBC, as well as a number of medical/diagnostic ‘flags’. The results were analyzed statistically, including an analysis of the correlation of each parameter between the two instruments, bias (whether there is a systematic shift between the two instruments), and slope (whether there is a systematic scaling factor between the two instruments’ results).

To ascertain what quality of results was necessary to declare OLO equivalent to the Sysmex XN, we relied on values that we discussed with the FDA in our three pre-submission meetings. We applied these quality targets to our recent clinical study despite the CE Mark not sharing the same stringent requirements as the FDA, and we found that we surpassed the targets. Accordingly, we believe that our data supports the claim that OLO is equivalent to standard central-lab tests, which is our goal: testing at the point-of-care without compromising accuracy or depth of information.

As Levner notes there, they have completed a 250-person clinical trial, which took place at Israel’s Shaare Zedek Medical Center — a testing process that led to them obtaining CE Mark registration for OLO; aka the health & safety certification that’s necessary for commercial sale within certain European countries. 

“For the CE Mark declaration, we have verified that OLO complies with the CE in vitro diagnostics directive (Directive 98/79/EC IVD). Accordingly, OLO meets the full list of harmonized standards that the directive requires, including ISO 13485 (quality management system), ISO 14971 (medical device risk management), CEN 13612 (medical device performance evaluation), and various safety, stability and labeling requirements,” he further says on that.

One important point to flag is that Sight Diagnostics has not yet published peer reviewed results of any of its clinical trials for OLO.

But Levner says the results of its most recent clinical trial (testing OLO as a CBC analyzer) are “currently in preparation” for publication in a peer-reviewed journal.

“We strongly believe in the necessity of sharing our data this way, but unfortunately and as you know, the process of publishing in academic journals tends to take several months,” he says, offering to share the results under a confidentiality agreement “so as not to scoop our own publication”.

Nor is OLO the team’s first blood diagnostic test. Previously they developed a diagnostic test for malaria (called Parasight), using digital fluorescent microscopy and computer vision algorithms — and they have three published journal articles that describe clinical trials on their malaria test.

Parasight was first deployed in 2014, and they say more than 600,000 of the malaria tests have been sold to date — claiming they have “accurately and consistently” diagnosed malaria in 25 countries.

Levner says the malaria test used the same underlying technologies they are now redeploying for OLO — including “common sample-preparation methods, microscope design, and artificial-intelligence based algorithms”.

While malaria testing was their first focus, they’re looking to build a far more expansive point-of-care blood diagnostics business with OLO — beginning with CBC testing but envisaging the system as a platform that will, in time, be capable of running a portfolio of blood tests. 

Although on this Levner is careful to note that each additional test would be added individually — and after “independent clinical validation”.

“We see OLO eventually consolidating a number of tests that are important to the doctor’s office and becoming a diagnostics nerve-center for the clinic,” he tells TechCrunch, adding: “We will introduce these additional tests one-by-one, with each test undergoing independent clinical validation.”

Sight Diagnostics is starting by selling OLO in Europe, with both private doctors’ offices and national health services in its sights. Levner says they’re expecting the device to be in doctors’ offices in the EU in “around three months” — noting they’re in the process of finishing up a couple of initial distribution agreements now.

“Ultimately, we intend to distribute OLO in all of Europe and beyond. However, we are prioritizing European countries that are known for being early adopters — for example, countries without a single-payer system or ones with a well-developed private market,” he adds.

He also confirms OLO has been registered in the EU using a Netherlands-based CE Notified Body.

“We are also pursuing several more national registrations that don’t require additional testing, such as Switzerland and Israel, which otherwise accept the CE Mark.”

The team is also conducting a study as part of FDA testing in the US — with a trial ongoing at three US-based sites. They’re aiming to admit more than 500 participants, and are using eight different OLO instruments for testing.

The initial push is to obtain 510(k) approval from the FDA, which would allow OLO to be used in larger US-based clinics (CLIA certified facilities). Levner says they hope to gain that approval “midway through next year”.

The subsequence step would be to obtain a CLIA waiver from the FDA — which would permit it to place instruments in small clinics and doctor’s offices — necessary to the stated goal of “bringing blood diagnostics to the point-of-care”. And the hope is they obtain that waiver in 2020. Though clearly there’s a long way to go to pass all the necessary clinical regulatory hurdles.

In addition to the co-founders, Levner says the team includes a number of medical, diagnostics and regulatory experts — naming Dr Shai Izraeli (Hematology-Oncology) and Janice Hogan (who he says has previously developed regulatory strategy for hematology analyzers) — as well as several diagnostics-industry experts he says he’s not currently at liberty to disclose.

He also says they recruited “renowned hematology experts” to lead their CBC clinical trials — naming one: Dr Carlo Brugnara, the director of the Hematology Lab at the Boston Children’s Hospital, who they quote in their press release, talking up the challenges for physicians of having to wait for blood test results, and saying: “Previous blood analyzers aimed at in-office testing have involved clinical compromises and are difficult to operate or maintain. OLO has the potential to deliver on the promise of accurate, comprehensive blood testing at the doctor’s office, even with a finger prick sample.”

Nearly half a petabyte of blood image data — sourced from Sight Diagnostics’ own clinical studies over the past four years — has been used to train the AIs powering the OLO blood diagnostics system. (Levner specifies this data “has been anonymized and used in accordance with ethical review (IRB) approvals from their respective clinical institutions”.)

While most of the additional tests they’re envisaging bringing to OLO in future would use the same single-use consumable model as the CBC test, he mentions a subset of tests they’ve been considering which could benefit from sending information digitally to a different facility.

“As one example, imagine that OLO is used to run a CBC for a patient, and an important finding is identified. In the future, the physician could order a follow-on test and have the already digitized blood images streamed to an expert,” he suggests. “The expert (or even multiple experts) could then analyze images remotely, saving the patient additional blood draws or travel.”

So while the initial business model is a traditional sales model — with Sight Diagnostics selling the OLO system plus as many test kits as required, and CBC tests taking place fully onboard the system, with no need for the device to connect to its servers — down the line, should all go to plan, there could be scope to bolt on a SaaS platform element. Such as for enabling clinicians to order additional follow on analyses, and with OLO streaming digitized blood images to remote experts. 

So if their technology is as accurate and robust as they claim, a lot more could flow from just a few drops of digitized blood.

News Source = techcrunch.com

Technology in healthcare is moving from mainframes to iPhones

in blood test/Column/Delhi/Health/Healthcare/HealthTech/India/Politics by

New technologies are often first manifested in behemoth machines that may take up entire rooms, only to be miniaturized as the technology matures. We have witnessed this shift over the last 70 years in computers, and an analogous trend is now underway in healthcare.

Startups across the world are transforming capabilities that were once relegated to specialty labs with large, expensive capital equipment and highly trained technicians. For example, in the early 2000s, Celera Genomics used nearly 300 DNA sequencers and 7,000 processors, and cost nearly $100 million to complete the sequence of one human genome. Today, an entire human genome can be run on a desktop machine for less than $1,000. Beyond DNA sequencing, new companies focusing on everything from flu to strokes are moving the technology, revenue and data from a few centralized companies to the doctors and patients that need it the most.

The benefits of these technologies are numerous. Disaggregating testing from large centralized labs to the clinic or the home will broadly lower costs, enhance patient outcomes and provide better overall access to care. Historically, the capital and operational costs of this large equipment have required centralized facilities to be amortized over many samples.

This industry can now benefit from the cost reductions enabled by the mass manufacturing of consumer electronics. Optics, microfluidics and electronics are nearly an order of magnitude less expensive than just a decade ago. Combined with novel chemistry and smarter software, these tests are at cost parity or better than their centralized counterparts.

PreDxion Bio believes that it has a blood test that could cut down on deaths in emergency rooms. The team says that previous blood tests often took over three days to get back and that about half a million people die per year because of the delays. They’ve built a test that can help doctors gain insight into inflammatory biomarkers, making it easier to treat things like trauma and burns. The startup is starting clinical trials this fall at UCSF, Mayo Clinic and Mount Sinai hospitals.

Beyond the costs of the tests themselves, the fees associated with hospital-based diagnostics have grown exponentially, and many labs are overloaded with patient samples. Additional costs due to factors such as hospital administration and insurance can quickly overtake the cost of a test itself.  In-clinic and in-home tests remove the overhead attributed to hospital operation, significantly reducing the overall cost of diagnostics.  These tests also improve the availability, as they remove the time waiting for equipment or staff.

It is well documented that a fast and accurate diagnosis are critical for ensuring patient outcomes across a wide variety of diseases. Quicker diagnosis enables the correct rapid treatment, minimizes hospitalization rates and reduces the over-prescription of antibiotics. By bringing these tools to the bedside and reducing time to diagnosis from days to minutes, the quality of patient outcomes will increase.

In-clinic and at home tests deliver a large amount of data for both providers and patients. Traditional diagnostics produce a single data point, while distributed tests enable time series data that can help to monitor trends. This type of data is necessary to catch conditions at their earliest stages, when they are most likely to be treated and cured properly. Leveraging this data to track behaviors, treatments and outcomes can have significant impact on how healthcare is delivered. There are also additional startup opportunities to collect, analyze and act upon this data.

These tests, however, are not without their challenges. They can be expensive to develop and certify, they may require changes to clinical workflows and there is strong competition from market incumbents. Also, although these tests may be smaller and less expensive, they are still held to same rigorous standards by the FDA and other regulatory agencies. The  510(k) pathway provides a less cumbersome  to pass regulatory scrutiny than a new therapeutic, but still require significant resources.

The fundamental driver of the adoption of these technologies, however, will be an optimization of economics for providers. By offering an in-clinic diagnostic test, the provider can bill the full cost of that test, rather than having to outsource it to a centralized lab. Telemedicine has been impaired by the lack of definitive tests available to patients at home. However, an over the counter flu test can enable a telemedicine company to charge for a diagnostic and therapeutic visit while the provider is still 1,000s of miles away. Each of these attributes provide increase economic benefit to both the patient and the provider.

The shift from large, centralized testing facilities, to in-clinic and at-home tests has begun. These tests provide an increased quality of care, while decreasing the costs incurred across the value-chain. Their adoption is inevitable. Significant investment is still required to develop these tests to a cost and performance acceptable to the healthcare system, and there are many sources of funding currently supporting these innovations. Many entrepreneurs have identified opportunities to make meaningful impacts across society, and entire generations to come will live longer, healthier lives because of it.

News Source = techcrunch.com

Gear for making outdoor fitness more enjoyable

in Column/Delhi/electronics/Garmin/Global Positioning System/gps/Health/India/plantronics/Politics/Wearables/Wirecutter by

Editor’s note: This post was done in partnership with Wirecutter. When readers choose to buy Wirecutter’s independently chosen editorial picks, Wirecutter and TechCrunch earn affiliate commissions.     

Exercising outdoors comes with space, terrain and, if you’re lucky, a nice breeze that you don’t get in a gym. While fitness fanatics care most about completing a good workout, having the right gear to help with keeping track of progress — and getting on with your day when you’re done — makes a big difference.

We’ve gathered some of our favorite fitness wearables, headphones and accessories that improve and make outdoor workout routines more enjoyable.

Running headphones: Plantronics BackBeat Fit

We’ve tested 31 pairs of running headphones and for two years the Plantronics BackBeat Fit has remained our top recommendation. The ergonomics and comfort that the BackBeat Fit offer is impressive and they’re built to combat sweat, dust and rain. The cable that connects the earbuds is accommodating for heads of all sizes and it won’t bounce around or be an annoyance while you work out. Jogging at night or in a busy neighborhood will be a bit safer and easier to navigate as the BackBeat Fit has unsealed earbuds that are designed to allow you to hear your surroundings.

Everything I fit into my Arkel Bug for a day of working away from home. (Photo: Eve O’Neill)

Backpack pannier: Arkel Bug Pannier Backpack

Bike riding is a form of exercise that’s enjoyable for many. A bike is also a convenient mode of transportation, and equipping it with gear like a bike lock, rear rack and pannier can make heading out on the trail even more worthwhile. If in-between or after your ride you’d prefer to run errands, hang out or work, we recommend carrying your belongings in the Arkel Bug Pannier Backpack.

It’s spacious and has mesh material that repels water. We like that it’s durable enough to hold heavier items and it has a deep back pocket that’s big enough for a road or urban style helmet.                                                                                                                 

The Forerunner 235 (front) is thinner and sits more evenly on your wrist than its predecessor, the Forerunner 225.

GPS Running Watch: Garmin Forerunner 235

The ease of operating the Garmin Forerunner 235 makes it a great GPS running watch for beginners. Its optional apps and ability to track advanced metrics makes it great for experienced runners. You’ll be able to use data to create and follow customized workouts, as well as review details about intensity and volume.

The FR 235 delivers heart-rate tracking without the use of a chest strap and it isn’t as bulky as previous generations. Its Auto Pause feature helps with accurately tracking pace and running data when you make stops (i.e. at an intersection) during runs.

The Garmin Vivosport is the most versatile and accurate tracker we’ve found. (Photo: Michael Hession)

Fitness tracker: Garmin Vivosport

For a simple rundown of your heart rate, the number of steps you’ve taken and the distance you’ve traveled, a fitness tracker will do the trick. Our top pick, the Garmin Vivosport, has optional GPS tracking capabilities, accurate stats and overall solid performance that places it above a standard fitness tracker.

If keeping your phone on you for listening to music is a must, you can use the Vivosport to control playback and receive notifications. It measures stress levels, tracks sleep and automatically detects activity. When you’re lifting weights without a buddy, its strength-training mode can be enabled to do rep counting for you.

Photo: Kyle Fitzgerald

Water bottle: Klean Kanteen Classic 27-ounce stainless-steel bottle with 3.0 Sport Cap

Whether your workout consists of high-intensity cardio or a casual walk in the park, it’s important to stay hydrated. Bringing along a light, durable water bottle means you won’t have to find a place to grab a drink and you’ll have a handy go-to when you need a refresher.

The Klean Kanteen Classic 27-Ounce Stainless Steel Bottle with 3.0 Sport Cap is our top pick for a steel water bottle because it’s easy to clean, has swappable caps and, more importantly, less than favorable tastes and smells don’t linger around. Its 1¾-inch mouth is big enough to fit ice cubes but not so big that water will spill on your new shoes if you take a sip while running.

This guide may have been updated by WirecutterNote from Wirecutter: When readers choose to buy our independently chosen editorial picks, we may earn affiliate commissions that support our work.

News Source = techcrunch.com

Instagram’s Do Not Disturb and “Caught Up” deter overgramming

in Apps/Delhi/Facebook/Facebook time well spent/Health/India/instagram/Instagram Time Well Spent/Instagram Usage Insights/mobile/Politics/Social/TC/Time Well Spent by

Instagram is turning the Time Well Spent philosophy into features to help users avoid endless scrolling and distraction by notifications. Today, Instagram is rolling out its “You’re All Caught – You’ve seen all new posts from the past 2 days” warning in the feed which TechCrunch broke the news about in May. Past that notice will only be posts that iOS and Android users have already seen or that were posted more than 48 hours ago. This will help Instagram’s 1 billion monthly users stop fiendishly scrolling in search of new posts scattered by the algorithm. While sorting the feed has made it much better at displaying the most interesting posts, it can also make people worry they’ve missed something. This warning should give them peace of mind.

Meanwhile, TechCrunch has learned that both Facebook and Instagram are prototyping Do Not Disturb features that let users shut off notifications from the apps for 30 minutes, 1 hour, 2 hours, 8 hours, 1 day, or until they’re turned back on manually.  WhatsApp Beta and Matt Navarra spotted the Instagram and Facebook Do Not Disturb features. Facebook is also considering allowing users to turn off sound or vibration on its notifications. Both apps have these Do Not Disturb features buried in their code and may have begun testing them.

Both Facebook and Instagram declined to comment on building new Do Not Disturb features. “You’re All Caught Up” could prevent extra scrolling that doesn’t provide much value that could make Instagram show up atop your list of biggest time sinks. And an in-app Do Not Disturb mode with multiple temporary options could keep you from permanently disabling Instagram or Facebook’s


We referenced Instagram Do Not Disturb our scoop about Instagram building a Usage Insights dashboard detailing how much time you spent on the app. Both Facebook and Instagram are preparing these screens that show you how much time you’ve spent on their apps per day, in average over the past week, and that let you set a daily limit after which you’ll get a notification reminding you to look up from your screen.

When we first reported on Usage Insights, Instagram CEO Kevin Systrom has tweeted a link to the article, confirming that Instagram was getting behind the Time Well Spent movement. “It’s true . . . We’re building tools that will help the IG community know more about the time they spend on Instagram – any time should be positive and intentional . . . Understanding how time online impacts people is important, and it’s the responsibility of all companies to be honest about this. We want to be part of the solution. I take that responsibility seriously.”

Now we’re seeing this perspective manifest itself in Instagram’s product. Instagram’s interest conveniently comes just as Apple and Google are releasing Screen Time and Digital Well-Being tools as part of the next versions of their mobile operating systems. These will show you which apps you’re spending the most time in, and set limits on their use. By self-policing now, Instagram and Facebook could avoid being out by iOS and Android as the enemies of your attention.

In other recent Instagram news:

News Source = techcrunch.com

ExceptionAlly helps parents navigate the special needs education labyrinth

in Accelerator/accessibility/Delhi/Education/exceptionally/Health/India/Politics/special education/special needs/Startups/TC/Y Combinator by

The challenges faced by parents of kids with special needs are always unique, but in one way they are surely much alike: making sure the kids are getting what they need from schools is way harder than it ought to be. ExceptionAlly is a new startup that aims to help parents understand, organize and communicate all the info they need to make sure their child is getting the help they require.

“There are millions of parents out there trying to navigate special education. And parents with special needs should have access to more information than what one school tells them,” said ExceptionAlly co-founder and CEO Rayford Davis. “Those with the means actually hire special education attorneys, but those are few and far between. We thought, how can we democratize this? So we’re trying to do what TurboTax did for CPAs: deliver a large percentage of the value for a small percentage of the cost.”

The company just emerged from Y Combinator and is pursuing full deployment ahead of this school year, with a visibility push during the usual back-to-school dates. It’s still early days, but Davis tells me they already have thousands of users who are taking advantage of the free and paid aspects of the service.

Just because a parent has a kid with dyslexia, or a hearing impairment, or a physical disability, doesn’t mean they suddenly become an expert in what resources are out there for those kids — what’s required by law, what a school offers voluntarily and so on. Achieving fluency in these complex issues is a big ask on top of all the usual parental duties — and on top of that, parents and schools are often put in adversarial positions.

There are resources out there for parents, certainly, but they’re scattered and often require a great deal of effort on the parents’ part. So the first goal of the service is to educate and structure the parents’ information on the systems they’re dealing with.

Based on information provided by the parent, such as their kid’s conditions or needs, and other information like school district, state and so on, the platform assists the parent in understanding both the condition itself, what they can expect from a school and what their rights are. It could be something as simple as moving a kid to the front row of a classroom to knowing how frequently the school is required to share reports on that kid’s progress.

Parents rarely know the range of accommodations a school can offer, Davis said, and even the schools themselves might not know or properly explain what they can or must provide if asked.

For instance, an IEP, or individual education plan, and yearly goals are required for every student with special needs, along with meetings and progress reports. These are often skipped or, if not, done in a rote way that isn’t personalized.

Davis said that by helping parents collaborate with the school and teacher on IEPs and other facets of the process, they accomplish several things. First, the parent feels more confident and involved in their kid’s education, having brought something to the table. Second, less pressure is put on overworked teachers to produce these things in addition to everything else they have to do. And third, it either allows or compels schools to provide all the resources they have available.

Naturally, this whole process produces reams of documents: evaluations, draft plans, lesson lists, observations, reports and so on. “If you talk to any parent of a child with special needs, they’ll tell you how they have file cabinets full of paperwork,” Davis said.

ExceptionAlly will let you scan or send it all these docs, which it helps you organize into the various categories and find again should you need them. A search feature based on OCR processing of the text is in development and should be in place for the latter half of the coming school year, which Davis pointed out is really when it starts being necessary.

That, he said, is when parents need to keep schools accountable. Being informed both on the kid’s progress and what the school is supposed to be doing lets the resulting process be collaborative rather than combative. But if the latter comes to pass, the platform has resources for parents to deploy to make sure the schools don’t dominate the power equation.

“If things progress that way, there’s a ‘take action toolkit’ to develop communications with the school,” Davis said. Ideally you don’t want to be the parent threatening legal action or calling the principal at home. A timely reminder of what was agreed upon and a nudge to keep things on track keeps it positive. “It’s sort of a reminder that we should all be on ‘team kid,’ if you will,” he added.

Schools, unfortunately, have not shown themselves to be highly willing to collaborate.

“We spent about six months talking to over a hundred schools and districts. What we found was not a lot of energy to provide parents with any more information than what the school was already providing,” Davis explained.

The sad truth here is that many schools are already neck-deep in administrative woes, the teachers are overworked and have new responsibilities every year and the idea of volunteering for new ones doesn’t strike even the most well-intentioned schools as attractive. So instead, ExceptionAlly has focused on going directly to parents, who, confidently and well-armed, can take their case to the school on their own.

“Listen, we’re not getting ready to solve all of education today with our solution. We’re going to find that one mom who says, ‘I know there’s more out there, can someone help me find it?’ Yes, we’re going to help you do that,” he said. “Could that put pressure on the system? As long as it does it legally and lawfully, I am perfectly okay with advocating for a child and parents’ legal rights and putting pressure on the system to give them what they by law deserve.”

After the official launch ahead of this school year, the company plans to continue adding features. Rich text search is among them, and deeper understanding of the documents could both help automate storage and retrieval and also lead to new insights. At some point there will also be an optional program to submit a child’s information (anonymously, of course) to help create a database of what accommodations in which places and cases led to what outcomes — essentially aggregating information direct from the source.

ExceptionAlly has some free content to peruse if you’re curious whether it might be helpful for you or someone you know, and there are a variety of paid options should it seem like a good fit.

News Source = techcrunch.com

1 2 3 18
Go to Top